Home
Health
Aspirin halves chances of bowel and womb cancer

Aspirin halves chances of bowel and womb cancer

Friday, 28 October 2011 9:49 AM

Taking two aspirins a day could help cut the number of hereditary cancers by half.

Latest Health News

Half of Brits misjudge their skin tone

When asked to describe their skin tone, half of Brits think their skin is darker than it actually is, new research revealed.

Is the sun really that bad for you?

New research from the University of Edinburgh found that the sun's rays could help reduce blood pressure, heart attack and stroke risk.

Quarter of adults only walk for 60 minutes a week

Brits are falling short of their recommended weekly exercise targets with a quarter only walking for an hour each week.

Scientists have discovered that taking regular aspirin halves the risk of developing hereditary cancers.

Bowel and womb cancers are the most common forms of hereditary cancers, which develop as a result of a gene fault inherited from a parent.

Fifty thousand people in the UK are diagnosed with bowel and womb cancers every year; and ten per cent of these cancers are thought to be hereditary.

The decade-long study, which involved scientists and clinicians from 43 centres in 16 countries and was funded by Cancer Research UK, followed nearly 1,000 patients, in some cases for over ten years.

The study, published in The Lancet, found that those who had been taking a regular dose of two aspirin tablets a day had 50 per cent fewer incidences of hereditary cancer compared with those who were not taking aspirin.

The research focused on people with Lynch syndrome which is an inherited genetic disorder that causes cancer by affecting genes responsible for detecting and repairing damage in the DNA.

Around 50 per cent of those with Lynch syndrome develop cancer, mainly in the bowel and womb. The study looked at all cancers related to the syndrome, and found that almost 30 per cent of the patients not taking aspirin had developed a cancer compared to around 15 per cent of those taking the aspirin.

Those who had taken aspirin still developed the same number of polyps, which are thought to be precursors of cancer, as those who did not take aspirin but they did not go on to develop cancer. It suggests that aspirin could possibly be causing these cells to destruct before they turn cancerous.

Professor Patrick Morrison from Queen's University in Belfast, who led the Northern Ireland part of the study, said: "The results of this study, which has been ongoing for over a decade, proves that the regular intake of aspirin over a prolonged period halves the risk of developing hereditary cancers."

"This is a huge breakthrough in terms of cancer prevention. For those who have a history of hereditary cancers in their family, like bowel and womb cancers, this will be welcome news.

"For anyone considering taking aspirin I would recommend discussing this with your GP first as aspirin is known to bring with it a risk of stomach complaints, including ulcers."

Want to be the first to hear all our health, fitness and beauty news? Follow @TotallyLiving on Twitter.